Mavoglurant
- Generic Name
- Mavoglurant
- Drug Type
- Small Molecule
- Chemical Formula
- C19H23NO3
- CAS Number
- 543906-09-8
- Unique Ingredient Identifier
- GT0I9SV4F6
- Background
Mavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).
Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
- First Posted Date
- 2009-09-30
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Novartis
- Target Recruit Count
- 260
- Registration Number
- NCT00986414
- Locations
- π¨π¦
Toronto Western Hospital, UHN, Toronto, Canada
πͺπΈNovartis Investigative Site, San Sebastian, Spain
π¦πΊNovartis Investigational Site, Westmead, Australia
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients
Phase 2
Completed
- Conditions
- L-dopa Induced DyskinesiaParkinson's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- Novartis
- Target Recruit Count
- 28
- Registration Number
- NCT00888004
- Locations
- π©πͺ
Novartis Investigative Site, Tubingen, Germany
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa
- First Posted Date
- 2007-12-28
- Last Posted Date
- 2010-05-14
- Lead Sponsor
- Novartis
- Target Recruit Count
- 31
- Registration Number
- NCT00582673
- Locations
- π©πͺ
Novartis Investigator Site, Tuebingen, Germany
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
Phase 1
Completed
- Conditions
- Gastroesophageal Reflux Disease
- First Posted Date
- 2006-12-22
- Last Posted Date
- 2007-06-22
- Lead Sponsor
- Novartis
- Target Recruit Count
- 34
- Registration Number
- NCT00414856
- Locations
- π¨π
Novartis Investigative site, Bern, Switzerland
π©πͺNovartis Investigative Site, Nuernberg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath